Industry Analysis Report | 2018

Publish date: August 2019

Login to access report

DRG’s Pharma Industry Report provides pharma executives with a comprehensive summary of the current and future state of the global pharmaceutical industry.

Scope

This report pulls together key information about the global pharmaceutical market from across our Company & Drug Insights content. We analyze the top selling brands, companies, and therapeutic areas. We evaluate the leading competitors in terms of their ethical drug sales, strategic focus, current drivers, patent exposure, and pipeline projects. We compare the different therapeutic areas in terms of their global sales and highlight the leading competitors and pipeline drugs within each area to provide you with a comprehensive summary of the global market.

Companies Mentioned

  • Abbvie
  • Allergan
  • Amgen
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Daiichi-Sankyo
  • Eli Lilly
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Shire
  • Takeda
  • Teva

Questions answered in this report

  • Who are the leading competitors in the global pharmaceutical industry? What are their current drivers and areas of R&D? What is their timeline for patent exposure?
  • How do the different therapy areas rank in terms of size and relative growth? How do their global sales break down by drug technology, and what are the leading pipeline projects?
  • What are the leading drugs according to global sales, and how will these rankings change by 2024?